 |
|
|
|
|
Innovative transaction strategies are more critical than ever to creating corporate value in the life sciences.
Apeiron Partners has learned how to create value and reduce risk by fitting the right transaction strategy to a particular business situation. Apeiron Partners has experience formulating strategy and executing it in over 40 engagements for innovative life science companies. In addition, as published in Innovation that Fits: Moving Beyond the Fads to Choose the Right Innovation Strategy for Your Business (2005), by Pearson Education, Inc. publishing as Prentice Hall, co-authored by Apeiron’s founder Jeff Wager, Apeiron Partners has studied over 250 corporate innovation initiatives that relied on 6 major new models of innovation and drawn important conclusions about how to design and execute transaction strategies.
Corporate Spin-Outs
|
|
|
Apeiron Partners is the only firm dedicated to the design and execution of corporate spin-outs in the life science space on behalf of parent companies. Apeiron Partners provides the parent company with a fully outsourced solution to the spin-out strategy and implementation process. By so doing, it conserves and focuses parent resources and maximizes the economic and strategic position of the parent in the structure. A key element in this is the organization and optimization of a highly-optimized syndicate of value-added investors and partners for the spin-out.
|
|
|
Mergers & Acquisitions
|
|
|
Apeiron Partners’ core M&A focus is in identifying disparities between the life science communities of Europe and North America and to then design and execute strategies that create value through leveraging these differences.
|
|
|
Private Placements
|
|
|
Apeiron Partners assists management in developing and communicating a differentiated value proposition to the financial community. This also frequently involves refocusing the client’s corporate and R & D strategy, identification and recruitment of board members, and other pre-financing activities. Apeiron Partners then designs an optimal financing strategy and recruits strategic investors that will enable maximum value creation of the company.
|
|
|
Strategic Alliances
|
|
|
Apeiron Partners creatively identifies synergistic partners and key drivers for success from the perspectives of both parties. We then quantitatively determine the value of the alliance from each partner’s perspective and structure an alliance management framework that maximizes the chances for alliance success. Utilizing this approach, we shorten the time to achieve a mutually acceptable deal, create a “win-win” atmosphere, and facilitate the successful implementation of product development.
|
|
|
Newco Incubations
|
|
|
Apeiron Partners maximizes the value of client assets by incubating new start-ups in its offices and providing interim staff as necessary to position the company for a fundraise involving world-class investors. Apeiron Partners seeks to optimize and integrate corporate, R&D, organizational and financial strategies of the start-up to ensure its success, and is intimately involved in the recruitment of senior management, key board members and advisors, and in the crafting of innovative R & D strategies which maximize the strategic and financial return on capital deployed.
|
|
|
Investment Advisory Services
|
|
|
Apeiron Partners is the advisor to Z-Cube s.r.l., the corporate venture capital arm of Zambon Group SpA of Milan, Italy, a multinational pharma company with annual revenues of ~€500 million, to advise it on managing its investments in life science start-ups in areas of strategic therapeutic interest to Zambon.
|
|
|
|
|
